🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is 1) to compare the effectiveness and safety of ...
Status
Completed
Location
United States, Alabama
Start Date
2014-06
Trial ID
NCT02195427
Treatments Being Tested
A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate S...
Status
Completed
Location
KEMRI/Centre for Respiratory Diseases Research Siaya Clinical Research Annex
Start Date
2023-10-19
Trial ID
NCT05817422
Treatments Being Tested
Alemtuzumab is an antibody that reduces the strength of the immune system t...
Status
Recruiting
Location
Cincinnati Children's Hospital Medical Center
Start Date
2023-01-11
Trial ID
NCT05501756
Treatments Being Tested
Summary Currently, the COVID-19 pandemic has overtaken health systems world...
Status
Completed
Location
Adrián Palacios Chavarria
Start Date
2020-10-01
Trial ID
NCT04998253
Treatments Being Tested
This is a comparative retrospective study of the efficacy of platelet-rich ...
Status
Completed
Location
Multiple Locations
Start Date
2011-01-01
Trial ID
NCT05129800
Treatments Being Tested
The study is planned as a single-center, randomized, double-blind placebo-c...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT02538185
This study is to compare the Pharmacokinetics, Pharmacodynamics, safety, an...
Status
Completed
Location
Biotrial Inc
Start Date
2022-03-09
Trial ID
NCT05323708
This trial will investigate the pharmacokinetics, safety and tolerability o...
Status
Completed
Location
1297.1.002 Boehringer Ingelheim Investigational Site
Start Date
2011-12-01
Trial ID
NCT01505491
Treatments Being Tested
Soft Tissue Adapted Biocompatible Hyaluronic Acid, or STABHA™, has demonstr...
Status
Unknown
Location
Multiple Locations
Start Date
2022-03-14
Trial ID
NCT05278897
Treatments Being Tested
Regeneron Pharmaceuticals developed a single-dose pre-filled syringe (PFS) ...
Status
Completed
Location
Retina Consultants of Texas
Start Date
2024-04-15
Trial ID
NCT05989126
Treatments Being Tested